THIS ISSUE

You can make an impact

“Positively Aware saved my life.”

Facing COVID in prison while living with HIV

A recently released inmate looks at the effects of quarantine—and stigma

PrEPared?

As long-acting treatment and prevention begins to enter communities, we must move toward dismantling systemic racism

The challenge of diagnosing HIV in people on long-acting PrEP

Impressive results from two efficacy trials of a long-acting form of the integrase inhibitor cabotegravir (CAB LA) have boosted prospects for long-acting HIV pre-exposure prophylaxis (PrEP). In both cases, CAB LA proved superior to oral Truvada PrEP (see table below).

‘Folks who need the most should get the most’

PACHA appointee Tori Cooper discusses the needs of the transgender community with PA associate editor Enid Vázquez

Transforming power

The transgender community takes the reins

Editor's Note Nov+Dec 2021

Communities left behind

Headline that reads "Straight, living with HIV, and invisible," with the word "invisible" faded out

Straight, living with HIV, and invisible

“HIV don’t care if you are black or white, or straight or gay.” —Eunice Marshall

EVERY ISSUE

Briefly Nov+Dec 2021

Long-acting PrEP with cabotegravir could be around the corner

Positively Aging: Measuring isolation and loneliness

There are a number of ways to look at support

 A woman covering her eyes

Being Bridgette

As a woman

SPECIAL SECTION - A DAY WITH HIV

Everyday moments in extraordinary lives

24-hour period in the lives of people affected by HIV